MedTrace Logo

Prostaglandin F2alpha in a Human Headache Model

NCT01327118 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-04-14

No results posted yet for this study

Summary

The hypothesis of this study is that PGF2alpha does not induce headache or dilatation of brain vessels.

Conditions

Interventions

DRUG

Prostaglandin F2alpha

intravenous injection

DRUG

Isoton sodium chloride

intravenous injection

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Troels Wienecke, MD,PhD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01327118 on ClinicalTrials.gov